Literature DB >> 15508374

Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?

Wayne Putnam1, Kelly Nicol, David Anderson, Brenda Brownell, Meredith Chiasson, Frederick I Burge, Gordon Flowerdew, Jafna Cox.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) substantially increases risk of stroke. Evidence suggests that anticoagulation to reduce risk is underused (a "care gap"). Our objectives were to clarify measures of this gap in care by including data from family physicians and to determine why eligible patients were not receiving anticoagulation therapy.
DESIGN: Telephone survey of family physicians regarding specific patients in their practices.
SETTING: Nova Scotia. PARTICIPANTS: Ambulatory AF patients not taking warfarin who had risk factors that made anticoagulation appropriate. MAIN OUTCOME MEASURES: Proportion of patients removed from the care gap; reasons given for not giving the remainder anticoagulants.
RESULTS: Half the patients thought to be in the care gap had previously unknown contraindications to anticoagulation, lacked a clear indication for anticoagulation, or were taking warfarin. Patients' refusal and anticipated problems with compliance and monitoring were among the reasons for not giving patients anticoagulants.
CONCLUSION: Adding data from primary care physicians significantly narrowed the care gap. Attention should focus on the remaining reasons for not giving eligible patients anticoagulants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508374      PMCID: PMC2214660     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

1.  Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?

Authors:  Frans H Rutten; Eelko Hak; Wim A B Stalman; Theo J M Verheij; Arno W Hoes
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

2.  General practitioners and the new contract: promoting better health through financial incentives.

Authors:  D Hughes
Journal:  Health Policy       Date:  1993-09       Impact factor: 2.980

3.  Recent national patterns of warfarin use in atrial fibrillation.

Authors:  R S Stafford; D E Singer
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

4.  A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.

Authors:  G Y Lip; D J Golding; M Nazir; D G Beevers; D L Child; R I Fletcher
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

5.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors:  A Howitt; D Armstrong
Journal:  BMJ       Date:  1999-05-15

6.  Screening for atrial fibrillation in primary care.

Authors:  N M Wheeldon; D I Tayler; E Anagnostou; D Cook; C Wales; G D Oakley
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

7.  Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.

Authors:  A Laupacis; K Sullivan
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

8.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

10.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

View more
  3 in total

1.  What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.

Authors:  Anders Ingelgård; Jennifer Hollowell; Prabashni Reddy; Karen Gold; Kimbach Tran; David Fitzmaurice
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

2.  Underutilization of Warfarin Therapy in Elderly Patients with Atrial Fibrillation - Fear or False Sense of Security!

Authors:  Mazda Biria; Ahmad Batrash; Jayasree Piallarisetti; James Vacek; Loren Berenbom; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

3.  Atrial fibrillation anticoagulation care in a large urban family medicine practice.

Authors:  Alissia Valentinis; Noah Ivers; Sacha Bhatia; Nazanin Meshkat; Kori Leblanc; Andrew Ha; Dante Morra
Journal:  Can Fam Physician       Date:  2014-03       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.